# Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma

> **NCT00393796** · PHASE2 · TERMINATED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 54 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** SUTENT
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00393796
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-05
- **Primary completion:** 2011-12
- **Final completion:** 2012-12
- **Target enrollment:** 54 (ACTUAL)
- **Why stopped:** Low accrual
- **Last updated:** 2014-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00393796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00393796, "Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00393796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*